# Insulin glulisine: UK patient leaflet, explained

Source: patient information leaflet for Apidra Solostar 100 Units/ml Solution For Injection In A Pre-Filled Pen (licence PLPI151842151), approved by the MHRA. Leaflet dated 2026-11-06. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/cd80fa1b9f4431b4ecf98a1abb01948618c9f4a5

Canonical page: https://pestle.health/uk/insulin-glulisine

## What is insulin glulisine for?
Apidra is a fast-acting antidiabetic medicine (insulin) used to reduce high blood sugar in people with diabetes mellitus. It can be given to adults, adolescents and children aged 6 years and older.

## Key facts
- Apidra starts to work within 10 to 20 minutes and lasts about 4 hours.
- It is injected under the skin shortly (0 to 15 minutes) before or soon after meals, and injection sites must be rotated.
- Low blood sugar (hypoglycaemia) is a very common side effect and can be serious, so always carry some sugar (at least 20 grams) and information showing you have diabetes.
- Do not stop using Apidra without speaking to a doctor, as this could lead to severe high blood sugar and ketoacidosis.
- Always check the insulin label before each injection to avoid mix-ups with other insulins.

## Who should not take insulin glulisine?
- If you are allergic to insulin glulisine or any of the other ingredients of this medicine
- If your blood sugar is too low (hypoglycaemia)

## Check with a doctor or pharmacist first if
- The pre-filled pen is only suitable for injecting just under the skin; speak to your doctor if you need to inject by another method
- Follow closely the instructions on dose, monitoring (blood tests), diet and physical activity discussed with your doctor
- If you have liver or kidney problems, you may need a lower dose
- There is insufficient clinical information on use in children younger than 6 years
- Rotate the injection site to prevent skin changes such as lumps; the insulin may not work well if injected into a lumpy area, so contact your doctor if you are doing this before changing area
- Talk to your doctor before travelling (insulin supplies, storage, meal and injection timing, time zones, emergencies)
- If you are ill or have a major injury, blood sugar may rise; if you are not eating enough, blood sugar may become too low; contact a doctor early
- If you have type 1 diabetes, do not stop your insulin and continue to get enough carbohydrates
- Heart failure has been seen in some patients with long-standing type 2 diabetes and heart disease or previous stroke treated with pioglitazone and insulin; tell your doctor if you have unusual shortness of breath, rapid weight increase or localised swelling (oedema)
- Alcohol may make your blood sugar rise or fall
- Your ability to concentrate or react may be reduced if your blood sugar is too low or too high, so take care when driving or using machines
- Apidra contains metacresol, which may cause allergic reactions

## Side effects that need urgent help
- Hypoglycaemia (low blood sugar), which can be very serious and may cause unconsciousness, brain damage and be life-threatening (very common, may affect more than 1 in 10 people)
- Systemic allergic reactions (uncommon, may affect up to 1 in 100 people): contact your doctor immediately
- Generalised allergy to insulin, with symptoms such as rash and itching all over the body, severe swelling of skin or mucous membranes (angioedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating, including anaphylactic reaction which may be life-threatening (listed with systemic allergic reactions, uncommon)
- Hyperglycaemia (high blood sugar), which can be serious if blood glucose becomes very high; severe hyperglycaemia or ketoacidosis must be treated by a doctor (frequency cannot be estimated)

## How common are the side effects?
### Very common (More than 1 in 10 people)
- Hypoglycaemia (low blood sugar)

### Common (Up to 1 in 10 people)
- Skin and allergic reactions at the injection site (reddening, unusually intense pain on injection, itching, hives, swelling or inflammation)

### Uncommon (Up to 1 in 100 people)
- Systemic allergic reactions (generalised allergy to insulin, including anaphylactic reaction)

### Rare (Up to 1 in 1,000 people)
- Lipoatrophy (shrinking of fatty tissue at the injection site)
- Lipohypertrophy (thickening of fatty tissue at the injection site)

### Not known (The leaflet says how often is not known)
- Cutaneous amyloidosis (lumps under the skin caused by build-up of amyloid)
- Hyperglycaemia (high blood sugar)
- Eye reactions (temporary disturbance of vision after a marked change in blood sugar control; temporary loss of vision with severe hypoglycaemic attacks if you have proliferative retinopathy)

## Other medicines the leaflet mentions
- Tell your doctor or pharmacist about any other medicines you are taking, have recently taken or might take
- Medicines that may lower blood sugar: all other medicines to treat diabetes, ACE inhibitors, disopyramide, fluoxetine, fibrates, MAO inhibitors, pentoxifylline, propoxyphene, salicylates (such as aspirin), sulphonamide antibiotics
- Medicines that may raise blood sugar: corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens (such as in the contraceptive pill), phenothiazine derivatives, somatropin, sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, protease inhibitors, atypical antipsychotic medicines (such as olanzapine and clozapine)
- Medicines that may raise or lower blood sugar: beta-blockers, clonidine, lithium salts
- Pentamidine, which may cause hypoglycaemia sometimes followed by hyperglycaemia
- Beta-blockers, clonidine, guanethidine and reserpine may weaken or hide the first warning symptoms of hypoglycaemia

## Pregnancy and breastfeeding
Ask your doctor or pharmacist for advice before use if you are pregnant, may be pregnant, are planning a baby or are breast-feeding. Your insulin dose may need to change during pregnancy and after giving birth, and careful diabetes control is important for your baby's health; there are no or limited data on use in pregnant women.

## How to take it
- Use it exactly as your doctor has told you; your doctor decides how much you need based on your life-style, blood sugar tests and previous insulin use.
- Inject under the skin of the abdominal wall, thigh or upper arm, shortly (0 to 15 minutes) before or soon after meals, and rotate injection sites each time.
- Before use, attach a new needle and do a safety test; only use the solution if it is clear, colourless and has no visible particles, and do not shake or mix it.
- Each pen must be used by one patient only; follow the SoloStar Instructions for Use.
- If you miss a dose, check your blood sugar frequently and do not take a double dose to make up for it.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
